##### Table of Contents



FORM 6-K
 SECURITIES AND EXCHANGE COMMISSION
 Washington, D.C. 20549
 Report of Foreign Private Issuer
 Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of 1934
 For the Month of June 2011
 Commission File Number  1-15182
 DR. REDDYS LABORATORIES LIMITED
  7-1-27, Ameerpet
Hyderabad, Andhra Pradesh 500 016, India
+91-40-23731946
 (Address of Principal Executive Offices)
  þ o
 o
 Note:
 o
 Note:
  o þ




---



##### 



Table of Contents
 (1) Press Release, Dr. Reddys announces three generic product launches in the US Market, June 6, 2011.(2) Press Release, Dr. Reddys Chemical Manufacturing Facility at Cuernavaca, Mexico Receives Warning
Letter from USFDA, June 14, 2011.(3) Press Release, Dr. Reddys announces the launch of Levofloxacin tablets, June 22, 2011.
   2




---



##### Table of Contents



Press Release
    
    (LOGO)Dr. Reddys Laboratories Ltd.8-2-337, Road No. 3Banjara Hills, Hyderabad  500 034Andhra Pradesh, IndiaTel: 91-40-4900-2900Fax: 91-40-4900-2999www.drreddys.com
 Dr. Reddys announces three generic product launches in the US Market
 Hyderabad, India, June 6, 2011
 
    
    Donepezil Hydrochloride tablets (5mg and 10mg strengths), a bioequivalent generic version
of ARICEPT® tablets*. The Food & Drug Administration (FDA) approved Dr. Reddys ANDA for
Donepezil HCl tablets on May 31, 2011. Both strengths of Dr. Reddys Donepezil Hydrochloride
tablets are available in 30, 90 and 500 count bottles.
 
    
    Venlafaxine Hydrochloride Extended Release capsules (37.5mg, 75mg and 150mg strengths), a
bioequivalent generic version of EFFEXOR XR® Extended Release capsules**. The Food & Drug
Administration (FDA) approved Dr. Reddys ANDA for Venlafaxine Hydrochloride Extended Release
Capsules on May 05, 2011. All three strengths of Dr. Reddys Venlafaxine Hydrochloride
Extended Release Capsules are available in 30, 90 and 500 count bottles.
 
    
    Letrozole tablets, USP (2.5mg), a bioequivalent generic version of FEMARA®***. The Food &
Drug Administration (FDA) approved Dr. Reddys ANDA for Letrozole tablets, USP on June 3,
2011. Dr. Reddys Letrozole tablets, USP are available in 30 count bottles.
 Notes to the editor:
 
    
    The ARICEPT® brand and Donepezil Hydrochloride tablets generic had total combined U.S.
sales of approximately $2.3 billion for the twelve months ending March 31, 2011 according to
IMS Health.
 
    
    The EFFEXOR XR® brand and Venlafaxine Extended Release Capsules generic had total combined
U.S. sales of approximately $2.3billion for the twelve months ending March 31, 2011 according
to IMS Health.
 
    
    The FEMARA® brand had U.S. sales of approximately $702 Million for the twelve months ending
March 31, 2011 according to IMS Health.
  *
    
    ARICEPT®, is a registered Trademark of Eisai R&D Management Co. Ltd.**
    
    EFFEXOR XR®, is a registered Trademark of Wyeth, LLC***
    
    FEMARA®, is a registered Trademark of Novartis Corporation Suicidality and Antidepressant Drugs
 Antidepressants increased the risk compared to placebo of suicidal thinking and
behavior (suicidality) in children, adolescents, and young adults in short-term
studies of major depressive disorder (MDD) and other psychiatric disorders.
Anyone considering the use of venlafaxine hydrochloride extended-release
capsules or any other antidepressant in a child, adolescent, or young adult
must balance this risk with the clinical need. Short-term studies did not show
an increase in the risk of suicidality with antidepressants compared to placebo
in adults beyond age 24; there was a reduction in risk with antidepressants
compared to placebo in adults aged 65 and older. Depression and certain other
psychiatric disorders are themselves associated with increases in the risk of
suicide. Patients of all ages who are started on antidepressant therapy should
be monitored appropriately and observed closely for clinical worsening,
suicidality, or unusual changes in behavior. Families and caregivers should be
advised of the need for close observation and communication with the
prescriber. Venlafaxine hydrochloride extended-release capsules are not
approved for use in pediatric patients. (See Warnings: Clinical Worsening and
Suicide Risk, Precautions: Information for Patients, and Precautions: Pediatric
Use)
  3




---



##### Table of Contents



Disclaimer
  About Dr. Reddys
 Pharmaceutical Services and Active Ingredients Global Generics Proprietary Products www.drreddys.com
 CONTACT INFORMATION
 Investors and Financial Analysts:
 kedaru@drreddys.com  raghavenderr@drreddys.com  mkalawadia@drreddys.com
 Media:
 rajans@drreddys.com
  4




---



##### Table of Contents



Press Release
    
    (LOGO)Dr. Reddys Laboratories Ltd.8-2-337, Road No. 3Banjara Hills, Hyderabad  500 034Andhra Pradesh, IndiaTel: 91-40-4900-2900Fax: 91-40-4900-2999www.drreddys.com
 Dr. Reddys Chemical Manufacturing Facility at Cuernavaca, Mexico Receives Warning Letter from
USFDA
 Hyderabad, India, June 14, 2011:
    Disclaimer
  About Dr. Reddys
 Pharmaceutical Services and Active Ingredients Global Generics Proprietary Products www.drreddys.com
 CONTACT INFORMATION
 Investors and Financial Analysts:
 kedaru@drreddys.com  raghavenderr@drreddys.com  mkalawadia@drreddys.com
 Media:
 rajans@drreddys.com
  5




---



##### Table of Contents



Press Release
    
    (LOGO)Dr. Reddys Laboratories Ltd.8-2-337, Road No. 3Banjara Hills, Hyderabad  500 034Andhra Pradesh, IndiaTel: 91-40-4900-2900Fax: 91-40-4900-2999www.drreddys.com
 Dr. Reddys announces the launch of Levofloxacin tablets
 Hyderabad, India, June 22, 2011:
 Levofloxacin tablets
(250 mg, 500 mg and 750 mg), ®
 ®
  Disclaimer
  About Dr. Reddys
 Pharmaceutical Services and Active Ingredients Global Generics Proprietary Products www.drreddys.com
 *
    
    LEVAQUIN®, is a registered trademark of Daiichi Sankyo Company, Limited. IMS National Sales Perspectives: Retail and Non-Retail MAT March 2011
 CONTACT INFORMATION
 Investors and Financial Analysts:
 kedaru@drreddys.com  raghavenderr@drreddys.com
 mkalawadia@drreddys.com
 Media:
 rajans@drreddys.com
  6




---



##### Table of Contents



DR. REDDYS LABORATORIES LIMITED(Registrant)By:
    
    /s/ Sandeep PoddarDate: July 5, 2011
    
    
    
    Name:
    
    Sandeep PoddarTitle:
    
    Company Secretary
  7